Bloomberg
S&P 500 E-Mini Futures Going Higher, 3D Capital's Dugan Says
Apr.18 -- On this edition of "Charting Futures," 3D Capital Management's Eric Dugan examines S&P 500 e-mini futures with Bloomberg's Abigail Doolittle on "Bloomberg Markets: The Close."
Bloomberg
The Startup That May Hold the Key to Extending Human Life
Cambrian Biopharma CEO James Peyer discusses the longevity startup's development of therapeutics to fight age-related diseases. He speaks with Bloomberg's Matt Miller on "Bloomberg Markets."
Bloomberg
How to Invest in Biotechs
Oct. 22 -- Oleg Nodelman, managing director of EcoR1 Capital, discusses investing in biotechnology and pharmaceutical stocks with Bloomberg's Stephanie Ruhle at the Robin Hood Investors Conference. (Source: Bloomberg)
Bloomberg
The MIT Media Lab's Next Breakthrough
May 11 -- Joi Ito, MIT Media Lab director, discusses the new environment for tech startups with Bloomberg's Emily Chang on "Bloomberg West."
Bloomberg
Cowen CEO Solomon Optimistic About Biotech, Cannabis and 5G
Jan.17 -- Jeffrey Solomon, Cowen Inc. chairman and chief executive officer, discusses his optimism about personalized medicine, the outlook for the cannabis industry and the rollout of 5G wireless technology. He speaks with Bloomberg's...
Curated Video
President urges EU to drop biotech ban
Washington, DC - June 23, 2003
1. Pan view of Convention Center
2. Mid view of screen showing blood cells
3. Mid view Swedish display
4. Close-up UK display
Pool
Washington, DC - June 23, 2003
5. Pull back view of Bush speaking
6....
Bloomberg
Tech's War on Cancer
June 14 -- Health industry experts talk at the Bloomberg Technology Conference about technological advancements in the fight against cancer. Speakers include: Helmy Eltoukhy, co-founder and CEO, Guardant and Michael Polansky, CEO, Parker...
Bloomberg
Asymmetric Opportunities Seen in Biotech Companies: Caliber Financial
Nov.18 -- Patrick Healey, founder and president of Caliber Financial Partners, shares his investment strategy for biotechnology stocks. He speaks with Kathleen Hays and Paul Allen on "Bloomberg Daybreak: Australia."
Bloomberg
Boston's Booming Cutting-Edge Biotech Scene
May 10 -- David Daly, Foundation Medicine's CCO, and Alexis Borisy, Third Rock Ventures partner, discuss Boston's booming biotech scene with Bloomberg's Emily Chang on "Bloomberg West."
Bloomberg
Bill Gates: Bio-Weapons 'Ultimate Misuse' of Technology
June 30 -- Billionaire Bill Gates, whose foundation seeks to spread modern medicine and wipe out diseases of the poor, says he supports the U.S. drug pricing system even as politicians have intensified their criticism of high costs. Bill...
Bloomberg
Reshaping the Pharma Industry
June 28 -- Jami Rubin, partner at Goldman Sachs, discusses the impact of Brexit on the pharmaceutical industry, research and development in the sector and companies she's keeping an eye on. She speaks to Bloomberg's Joe Weisenthal, Matt...
Bloomberg
Biotech’s Race for Drug Development
Jul.07 -- Nautilus Biotechnology Founder and CEO Sujal Patel discusses how his biotech startup company is developing a platform to measure and scan proteins in order to help accelerate drug development. He speaks with Emily Chang on...
Bloomberg
How to Find the Most Popular Trades on Robinhood
Jul.23 -- The site that tracks trading activity at retail brokerage Robinhood has attracted the attention of Wall Street. Hedge funds and other traders are looking to aggregate Robintrack.net data that shows how many accounts own any...
Bloomberg
Novavax Vaccine Will Probably Work on New Covid Strain: CEO
Dec.28 -- Novavax Inc. Chief Executive Officer Stan Erck discusses the phase 3 trial of the company's Covid-19 vaccine and says the data so far have been at or above the levels of Moderna Inc. and Pfizer Inc. He speaks with Bloomberg's...
Bloomberg
10X Genomics Strategy Driven By Innovation, CEO Says
Jan.12 -- 10X Genomics Inc. Chief Executive Officer Serge Saxonov discusses the company's strategy and performance amid the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
Bloomberg
Investing in Healthcare Beyond Covid
Jan.13 -- Noushin Irani, Portfolio Manager for Healthcare at DWS, discusses the best investment opportunities in the healthcare sector. She speaks with Matt Miller on "Bloomberg Markets: European Open."
Bloomberg
Julius Baer's Matthews Favors Commodity Firms, Biotech, PE
Mark Matthews, head of Asia research at Bank Julius Baer & Co. Ltd., discusses the sanctions imposed on Russia for its war with Ukraine and how those sanctions could impact global markets. He speaks on "Bloomberg Daybreak: Asia."
Bloomberg
'Bloomberg ETF IQ' (07/03/2019) - Health-Care Innovation ETF Launches As the Sector Lags in 2019
Jul.03 -- Bloomberg's Eric Balchunas and Taylor Riggs break down the ROBO Global Healthcare Technology and Innovation ETF (ticker: HTEC) with Jeremie Capron, director of research for ROBO Global. In addition, they discuss ‘ROBO’ - the...
Bloomberg
Biogen Soars as Surprise Alzheimer's Trial Results Fuel Hope
Jul.06 -- Biogen Inc. and Japanese partner Eisai Co. surged after a closely watched Alzheimer’s drug showed positive results in a large clinical trial, raising hopes for treatment of a disease that’s befuddled researchers for decades....
Bloomberg
Market Strategy: Growth in Financials and Biotech
Jan.09 -- Margaret Vitrano, portfolio manager at ClearBridge Investments, discusses finding growth in financials outside of the large money center banks, the impact of Dow 20,000, and offers her current investment strategy. She speaks on...
Bloomberg
Investing Tips From a Top-Performing Fund Manager
Feb. 25 -- Perceptive Advisors Founder and CEO Joseph Edelman discusses his investment strategies. He speaks on "Bloomberg ‹GO›."
Bloomberg
ETF Market Rides the Wave of a Biotech Boom
Mar.15 -- Bloomberg Intelligence's James Seyffart examines inflows and returns for biotech ETFs. He speaks on "Bloomberg Markets."
Bloomberg
Future Vaccines Have 'High Barrier' to Cross, Vir CEO Says
Dec.04 -- Vir Biotechnology Inc. Chief Executive Officer George Scangos says the manufacturing of vaccines is a highly regulated, complex process and the capacity to make drugs for Covid-19 is "somewhat limited." He speaks on "Bloomberg...
Curated Video
Therapeutic Drug Could Help Keep COVID-19 Patients Off Ventilators
AT-100 could help keep COVID-19 patients from going into respiratory distress and off of ventilators.